ROS can induce MAPK signaling activation, regulating the secretion of NF-κB-mediated inflammatory cytokines such as IL-1β, IL-6, and tumor necrosis factor-α, thereby modulating tumor cell inflammatory responses (127). The gene discussed is IL6; the disease is neoplasm.